Eton Pharmaceuticals Enters Into License Agreement for Two Branded Hospital Product Candidates Read more
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies Read more
Latest Developments in Combating Antifungal Resistance to be discussed by Industry Leaders at Superbugs & Superdrugs Conference in London Read more
Fate Therapeutics Announces FDA Clearance of IND Application for World’s First Cell Therapy Derived from an Engineered Pluripotent Stem Cell Read more